YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

NCT02710708 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1921

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: EE20/DRSP (YAZ, BAY86-5300)

Sponsor

Bayer